Clinical Trials

The Lipovaxin-MM-001 clinical trial — A Phase I Study of the Safety and Immunogenicity of escalating doses of Lipovaxin-MM, a novel melanoma immunotherapeutic in patients with metastatic melanoma was conducted at the Royal Adelaide Hospital. Recruitment was completed in 2011.